Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115406) titled 'Research Project on the Prevention and Control of Clonorchiasis (Subproject 1: Comparative Study on the Therapeutic Efficacy of Anthelmintic Drugs against Clonorchiasis)' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The People's Hospital of Guangxi Zhuang Autonomous Region
Condition:
Clonorchiasis
Intervention:
Tribendimidine Group:Tribendimidine: 0.4 g once daily (qd) for 3 days.
Albendazole Group:Albendazole: 10 mg/kg once daily (qd) for 7 days.
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-25
Target Sample Size: Tribendim...